Revolution, Ascendis, Arrowhead among RBC's top M&A candidates in biotech [Seeking Alpha]
Revolution Medicines, Inc. (RVMD)
Company Research
Source: Seeking Alpha
Revolution Medicines ( RVMD ), Ascendis Pharma ( ASND ), and Arrowhead Pharma ( ARWR ), among notable M&A contenders. RBC analyst Leonid Timashev based his analysis Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights Companies like Revolution Medicines, Ascendis Pharma, Arrowhead Pharma, Kymera Therapeutics, Rhythm Pharmaceuticals, Xenon Pharmaceuticals, Dyne Therapeutics, Viridian Therapeutics, BioCryst Pharmaceuticals, Wave Life Sciences, Ocular Therapeutix, Pharvaris, and EyePoint are highlighted as leading takeover candidates. M&A reports in outlets like Bloomberg and The Financial Times have historically led to significant short-term returns, such as median returns of 27% over 30 days and up to 70% over 90 days for target companies. Merck, AbbVie, Bristol Myers Squibb, Biogen, Vertex Pharmaceuticals, Regeneron, Jazz Pharmaceuticals, and Acadia Phar
Show less
Read more
Impact Snapshot
Event Time:
RVMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVMD alerts
High impacting Revolution Medicines, Inc. news events
Weekly update
A roundup of the hottest topics
RVMD
News
- Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Revolution Medicines to Showcase Progress Across RAS(ON) Targeted Oncology Pipeline with Multiple Presentations at the 2026 American Association for Cancer Research (AACR) Annual MeetingGlobeNewswire
- Revolution Medicines (RVMD) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.MarketBeat
- A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- This One Data Readout Could Make Or Break Revolution Medicines [Seeking Alpha]Seeking Alpha
RVMD
Earnings
- 2/25/26 - Miss
RVMD
Sec Filings
- 3/19/26 - Form 4
- 3/19/26 - Form 4
- 3/19/26 - Form 4
- RVMD's page on the SEC website